RedHill Biopharma Ltd. to Present at the 2013 Annual BioNetwork Conference
Published: Oct 23, 2013
TEL-AVIV, Israel, Oct. 23, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary formulations and combinations of existing drugs, today announced that Dror Ben-Asher, the Company's Chief Executive Officer, will present an overview of the Company at the 2013 Annual BioNetwork Conference, on Monday, October 28, 2013, at 12:15 p.m. EDT at the Ritz Carlton Hotel in Laguna Niguel, CA, U.S.
Help employers find you! Check out all the jobs and post your resume.